Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons.

J Med Liban. 1989;38(1):9-14. Unique Identifier : AIDSLINE MED/92045950
Mokhbat JE; Naman RE; Rahme FS; Farah AE; Zahar KL; Maalouf A

Abstract: A group of 64 multitransfused individuals with hemophilia or congenital hemolytic anemias were tested for antibodies against the human immunodeficiency virus. Thirty five of them were also evaluated clinically and their blood products supply was investigated. Only four hemophiliacs were found to be seropositive. The major risk factor that seemed associated with the acquisition of the virus was the transfusion of lyophilized factor VIII concentrate imported from the USA. A suggestion for control of transfusion associated infection and of contamination of hemophiliacs is presented.
Keywords: Adolescence Adult Blood Transfusion/*ADVERSE EFFECTS/STANDARDS Child Child, Preschool Factor VIII/SUPPLY & DISTRIBUTION/THERAPEUTIC USE Female Hemophilia/*THERAPY Human HIV Seropositivity/*EPIDEMIOLOGY/PHYSIOPATHOLOGY/TRANSMISSION Infant Lebanon/EPIDEMIOLOGY Male Middle Age Questionnaires Risk Factors Support, Non-U.S. Gov't Thalassemia/*THERAPY JOURNAL ARTICLEKWDadolescenceadultbloodtransfusion/KWDadverseeffects/standardschildchild,preschoolfactorviii/supply&distribution/therapeuticusefemalehemophilia/KWDtherapyhumanhivseropositivity/KWDepidemiology/physiopathology/transmissioninfantlebanon/epidemiologymalemiddleagequestionnairesriskfactorssupport,non-uKWDsKWDgov'tthalassemia/KWDtherapyjournalarticle
920228
M9220869

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .